HDAC9 and cancer: Chidamide is a novel and orally active benzamide-class HDAC inhibitor that selectively blocks the activities of HDAC1, HDAC2, HDAC3 and HDAC10, inducing growth arrest and apoptosis in certain cancers [16, 17].